{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:21:30Z","timestamp":1783603290786,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,16]]},"DOI":"10.7759\/cureus.82407","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:52:26Z","timestamp":1744869146000},"source":"Crossref","is-referenced-by-count":5,"title":["Prevalence and Predictors of Silent Myocardial Ischemia in Diabetic Patients"],"prefix":"10.7759","author":[{"given":"Hafiz","family":"Abdul Manan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammad Rauf","family":"Chishti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin Dzigbodi","family":"Hewlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74341","article-title":"Evaluating risk factors and the burden of silent myocardial ischemia among diabetic patients","volume":"16","author":"Arshad MM","year":"2024","unstructured":"Arshad MM, Hassan MA, Tahir M, Nawaz Khan MS, Gultasib MA, Ali G. Evaluating risk factors and the burden of silent myocardial ischemia among diabetic patients. Cureus. 2024, 16:e74341. 10.7759\/cureus.74341","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.040631","article-title":"Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury","volume":"140","author":"DeFilippis AP","year":"2019","unstructured":"DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK, Morrow DA. Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation. 2019, 140:1661-78. 10.1161\/CIRCULATIONAHA.119.040631","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.04.029","article-title":"Reviewing myocardial silent ischemia: specific patient subgroups","volume":"124","author":"Xanthos T","year":"2008","unstructured":"Xanthos T, Ekmektzoglou KA, Papadimitriou L. Reviewing myocardial silent ischemia: specific patient subgroups. Int J Cardiol. 2008, 124:139-48. 10.1016\/j.ijcard.2007.04.029","journal-title":"Int J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-019-4798-3","article-title":"Congestive heart failure caused by silent ischemia and silent myocardial infarction : Diagnostic challenge in type\u00a02 diabetes","volume":"44","author":"Valensi P","year":"2019","unstructured":"Valensi P, Meune C. Congestive heart failure caused by silent ischemia and silent myocardial infarction : Diagnostic challenge in type\u00a02 diabetes. Herz. 2019, 44:210-7. 10.1007\/s00059-019-4798-3","journal-title":"Herz"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27302007000200018","article-title":"Silent myocardial ischemia screening in patients with diabetes mellitus","volume":"51","author":"Barthelemy O","year":"2007","unstructured":"Barthelemy O, Le Feuvre C, Timsit J. Silent myocardial ischemia screening in patients with diabetes mellitus. Arq Bras Endocrinol Metabol. 2007, 51:285-93. 10.1590\/s0004-27302007000200018","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115973","article-title":"The mystery of diabetic cardiomyopathy: from early concepts and underlying mechanisms to novel therapeutic possibilities","volume":"22","author":"Grubi\u0107 Rotkvi\u0107 P","year":"2021","unstructured":"Grubi\u0107 Rotkvi\u0107 P, Planini\u0107 Z, Liberati Pr\u0161o AM, \u0160iki\u0107 J, Gali\u0107 E, Rotkvi\u0107 L. The mystery of diabetic cardiomyopathy: from early concepts and underlying mechanisms to novel therapeutic possibilities. Int J Mol Sci. 2021, 22:5973. 10.3390\/ijms22115973","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneuro0504","article-title":"Diabetic neuropathy--a review","volume":"3","author":"Said G","year":"2007","unstructured":"Said G. Diabetic neuropathy--a review. Nat Clin Pract Neurol. 2007, 3:331-40. 10.1038\/ncpneuro0504","journal-title":"Nat Clin Pract Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-016-1527-2","article-title":"Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension","volume":"12","author":"Rendina D","year":"2017","unstructured":"Rendina D, Ippolito R, De Filippo G, et al.. Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension. Intern Emerg Med. 2017, 12:171-9. 10.1007\/s11739-016-1527-2","journal-title":"Intern Emerg Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2217\/fca.10.127","article-title":"Myocardial ischemia: a silent epidemic in Type 2 diabetes patients","volume":"7","author":"Le Feuvre C","year":"2011","unstructured":"Le Feuvre C, Jacqueminet S, Barthelemy O. Myocardial ischemia: a silent epidemic in Type 2 diabetes patients. Future Cardiol. 2011, 7:183-90. 10.2217\/fca.10.127","journal-title":"Future Cardiol"},{"key":"ref10","article-title":"Prevalence and clinical significance of silent myocardial ischemia","volume":"80","author":"Parmley WW","year":"1989","unstructured":"Parmley WW. Prevalence and clinical significance of silent myocardial ischemia. Circulation. 1989, 80:IV68-73.","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s1262-3636(07)70187-8","article-title":"Markers for silent myocardial ischemia in diabetes. Are they helpful?","volume":"31","author":"Cosson E","year":"2005","unstructured":"Cosson E, Attali JR, Valensi P. Markers for silent myocardial ischemia in diabetes. Are they helpful?. Diabetes Metab. 2005, 31:205-13. 10.1016\/s1262-3636(07)70187-8","journal-title":"Diabetes Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman JA","year":"2002","unstructured":"Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002, 287:2570-81. 10.1001\/jama.287.19.2570","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani A","year":"2018","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, et al.. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018, 379:633-44. 10.1056\/NEJMoa1800256","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.09.001","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"56","author":"Greenland P","year":"2010","unstructured":"Greenland P, Alpert JS, Beller GA, et al.. 2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010, 56:e50-103. 10.1016\/j.jacc.2010.09.001","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox CS","year":"2012","unstructured":"Fox CS, Matsushita K, Woodward M, et al.. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012, 380:1662-73. 10.1016\/S0140-6736(12)61350-6","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.241.19.2035","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel WB","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979, 241:2035-8. 10.1001\/jama.241.19.2035","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian D","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al.. Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association. Circulation. 2016, 133:e38-360. 10.1161\/CIR.0000000000000350","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.11648\/j.ajtas.20160501.11","article-title":"Comparison of convenience sampling and purposive sampling","volume":"2016","author":"Etikan I","unstructured":"Etikan I, Musa SA, Alkassim RS. Comparison of convenience sampling and purposive sampling. American journal of theoretical and applied statistics. 2016:1-4. 10.11648\/j.ajtas.20160501.11","journal-title":"American journal of theoretical and applied statistics"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","year":"2016","unstructured":"Worldwide trends in diabetes since 1980. a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016, 387:1513-30. 10.1016\/S0140-6736(16)00618-8","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.117212","article-title":"Emerging risk factors for cardiovascular diseases: Indian context","volume":"17","author":"Gupta S","year":"2013","unstructured":"Gupta S, Gudapati R, Gaurav K, Bhise M. Emerging risk factors for cardiovascular diseases: Indian context. Indian J Endocrinol Metab. 2013, 17:806-14. 10.4103\/2230-8210.117212","journal-title":"Indian J Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.dr.2013.08.003","article-title":"Sampling in developmental science: situations, shortcomings, solutions, and standards","volume":"33","author":"Bornstein MH","year":"2013","unstructured":"Bornstein MH, Jager J, Putnick DL. Sampling in developmental science: situations, shortcomings, solutions, and standards. Dev Rev. 2013, 33:357-70. 10.1016\/j.dr.2013.08.003","journal-title":"Dev Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/mono.12296","article-title":"II. More than just convenient: the scientific merits of homogeneous convenience samples","volume":"82","author":"Jager J","year":"2017","unstructured":"Jager J, Putnick DL, Bornstein MH. II. More than just convenient: the scientific merits of homogeneous convenience samples. Monogr Soc Res Child Dev. 2017, 82:13-30. 10.1111\/mono.12296","journal-title":"Monogr Soc Res Child Dev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-5273(02)00558-2","article-title":"Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease","volume":"90","author":"Falcone C","year":"2003","unstructured":"Falcone C, Nespoli L, Geroldi D, et al.. Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. Int J Cardiol. 2003, 90:219-27. 10.1016\/s0167-5273(02)00558-2","journal-title":"Int J Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-011-0210-9","article-title":"Clinical characteristics of silent myocardial ischemia diagnosed with adenosine stress 99mTc-tetrofosmin myocardial scintigraphy in Japanese patients with acute cerebral infarction","volume":"28","author":"Nomura T","year":"2013","unstructured":"Nomura T, Kusaba T, Kodama N, et al.. Clinical characteristics of silent myocardial ischemia diagnosed with adenosine stress 99mTc-tetrofosmin myocardial scintigraphy in Japanese patients with acute cerebral infarction. Heart Vessels. 2013, 28:27-33. 10.1007\/s00380-011-0210-9","journal-title":"Heart Vessels"},{"key":"ref25","unstructured":"American Diabetes Association; Understanding Your A1C Test. (2022). Accessed. 28\/03\/2025: https:\/\/professional.diabetes.org\/sites\/default\/files\/media\/ada-factsheet-understandingyoura1ctest.pdf."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01965-7","article-title":"The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction","volume":"22","author":"An Y","year":"2023","unstructured":"An Y, Xu BT, Wan SR, Ma XM, Long Y, Xu Y, Jiang ZZ. The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovasc Diabetol. 2023, 22:237. 10.1186\/s12933-023-01965-7","journal-title":"Cardiovasc Diabetol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S418520","article-title":"Correlation between glycemic variability and diabetic complications: a narrative review","volume":"16","author":"Huang L","year":"2023","unstructured":"Huang L, Pan Y, Zhou K, Liu H, Zhong S. Correlation between glycemic variability and diabetic complications: a narrative review. Int J Gen Med. 2023, 16:3083-94. 10.2147\/IJGM.S418520","journal-title":"Int J Gen Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2522\/ptj.20080008","article-title":"Diabetes-related microvascular and macrovascular diseases in the physical therapy setting","volume":"88","author":"Cade WT","year":"2008","unstructured":"Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008, 88:1322-35. 10.2522\/ptj.20080008","journal-title":"Phys Ther"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017044","article-title":"Association between silent myocardial infarction and long\u2010term risk of sudden cardiac death","volume":"10","author":"Cheng YJ","year":"2021","unstructured":"Cheng YJ, Jia YH, Yao FJ, Mei WY, Zhai YS, Zhang M, Wu SH. Association between silent myocardial infarction and long\u2010term risk of sudden cardiac death. J Am Heart Assoc. 2021, 10:e017044. 10.1161\/JAHA.120.017044","journal-title":"J Am Heart Assoc"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/01.crd.0000188034.76283.5e","article-title":"Management of dyslipidemia in diabetes","volume":"14","author":"Solano MP","year":"2006","unstructured":"Solano MP, Goldberg RB. Management of dyslipidemia in diabetes. Cardiol Rev. 2006, 14:125-35. 10.1097\/01.crd.0000188034.76283.5e","journal-title":"Cardiol Rev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-s260","article-title":"Targets for intervention in dyslipidemia in diabetes","volume":"31 Suppl 2","author":"Tomkin GH","year":"2008","unstructured":"Tomkin GH. Targets for intervention in dyslipidemia in diabetes. Diabetes Care. 2008, 31 Suppl 2:S241-8. 10.2337\/dc08-s260","journal-title":"Diabetes Care"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-023-02824-w","article-title":"Regulation of endothelial function by cigarette smoke and next-generation tobacco and nicotine products","volume":"475","author":"Klein J","year":"2023","unstructured":"Klein J, Diaba-Nuhoho P, Giebe S, Brunssen C, Morawietz H. Regulation of endothelial function by cigarette smoke and next-generation tobacco and nicotine products. Pflugers Arch. 2023, 475:835-44. 10.1007\/s00424-023-02824-w","journal-title":"Pflugers Arch"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac270","article-title":"2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery","volume":"43","author":"Halvorsen S","year":"2022","unstructured":"Halvorsen S, Mehilli J, Cassese S, et al.. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022, 43:3826-924. 10.1093\/eurheartj\/ehac270","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/351581-prevalence-and-predictors-of-silent-myocardial-ischemia-in-diabetic-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:52:27Z","timestamp":1744869147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/351581-prevalence-and-predictors-of-silent-myocardial-ischemia-in-diabetic-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.82407","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}